Weider
This article was originally published in The Tan Sheet
Executive Summary
Schiff Move Free joint care sales of $31.7 mil. contribute to overall 1.3% sales increase to $91.2 mil. in fiscal first quarter (ended Aug. 31) despite "continued softening in industry and category trends," President & CEO Bruce Wood tells analysts Oct. 16. U.S. sales rose 2.2% to $65 mil.; consolidated net income rose 9% to $2 mil., although the increase reflects a one-time $3.5 mil. gain from a litigation settlement and $600,000 restructuring charge. New products and line extensions under Move Free, Weider, American Bodybuilding and Tiger's Milk brands achieved almost $6 mil. in sales. Weider plans to slow new product releases in FY 2001 and concentrate on top brands. Firm predicts continued flat revenues for the balance of the year and expects profitability from operating income
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning